Supplementary Table S4 from Predicting Clinical Sensitivities of PDGFRA Exon 18 Mutations to Imatinib and Avapritinib to Optimize Gastrointestinal Stromal Tumor Treatment
Year: 2026
Type: supplementary-materials
Abstract: Table S4. Imatinib IC50 values and 95% confidence intervals (CIs) of PDGFRA mutations modeled in Ba/F3 and CHO cells.
Authors: Homma M. Khosroyani, Alina Teuber, Ajia Town, Lillian R. Klug, Denisse Evans, Jerry Call, Sara Rothschild, Neeta Somaiah, Prapassorn Thirasastr, Mengyuan Liu, Ping Chi, Peter Hohenberger, Piotr Rutkowski, Patrick Schöffski, Abbas Agaimy, Mehdi Brahmi, Jonathan K. Killian, Garrett M. Frampton, Carol Beadling, Sebastian Bauer, Johanna Falkenhorst, Michael C. Heinrich
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7167407669
Cites:
Cited by:
Related to: